The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.

The (3;21)(q26;q22) translocation associated with treatment-related myelodysplastic syndrome, treatment-related acute myeloid leukemia, and blast crisis of chronic myeloid leukemia results in the expression of the chimeric genes AML1/EAP, AML1/MDS1, and AML1/EVI1. AML1 (CBFA2), which codes for the a...

Celý popis

Podrobná bibliografie

Vydáno v:	Proc Natl Acad Sci U S A
Hlavní autoři:	Zent, C S, Mathieu, C, Claxton, D F, Zhang, D E, Tenen, D G, Rowley, J D, Nucifora, G
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	National Academy of Sciences 1996
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC40027/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8577711/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.3.1044
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!